Genomate Health
Robert Doczi, PhD has an extensive background in research and molecular biology. Currently serving as the Head of Research at Genomate Health, they previously held positions such as Expert Evaluator at the European Commission and Head of Research at Oncompass Medicine. With a strong academic foundation, they obtained a Doctor of Philosophy (PhD) in Molecular Biology from Magyar Agrár- és Élettudományi Egyetem (MATE) and a Master of Science (MSc) in Biotechnology from the same institution. Their postdoctoral work was conducted at the Max F. Perutz Laboratories, University of Vienna, Vienna Biocenter.
This person is not in any teams
This person is not in any offices
Genomate Health
Genomate Health Inc. is a digital health company that develops AI-powered computational tools for personalized medicine. Our main focus is assisting physicians in making optimal personalized treatment decisions for each patient based on the complex molecular characteristics of human diseases. Our flagship product, Genomate™ MTC (Molecular Treatment Calculator), is the first computational AI solution that has been clinically proven to improve personalized N-of-1 treatment decisions in precision oncology. It automates data compilation, evaluation, and synthesis in a knowledge model allowing standardized, personalized treatment decisions based on the totality of available molecular information. We're currently partnering with cancer centers, molecular diagnostic companies, insurance companies, health funds, and pharma companies to advance access to effective targeted therapies for cancer patients worldwide. Do you want to join us?